BACE1 and gastric cancer: Recently, BACE1 has been reported to be abnormally expressed in a variety of tumors and is associated with poor prognosis in colon cancer, non-small-cell lung cancer, invasive ductal carcinoma of the breast, glioblastoma, and gastric cancer [14–18].